B-SMART in the headlines of AZoNano

AZoNano, the leading online publication platform for the nanotechnology community, has recently published a news article on the EU funded research project B-SMART to reach a worldwide audience of researchers, engineers and scientists in the field of nanotechnology.

The article highlights the project’s aim of using RNA based therapeutics to silence the production of disease-causing proteins for a range of neurodegenerative disorders, such as Parkinson’s, Alzheimer’s and Huntington’s. For a controlled production of nanomedicines, Precision NanoSystems' NanoAssemblr™ platform has been chosen in the frame of the B-SMART project to achieve this goal.

“RNA medicines are interesting because you can use what is essentially the same polynucleotide molecule to treat multiple diseases, just by changing the nucleotide sequence. Our goal is therefore to design modular nanoparticles capable of delivering a payload of therapeutic RNAs to the brain, allowing them to prevent the biosynthesis of harmful proteins at source,” Professor Raymond Schiffelers from Universitair Medisch Centrum Utrecht (UMC Utrecht) and coordinator of the B-SMART project explains.

Read the full article published by AZoNano here.

Tweet this article